BECTON DICKINSON & CO (NYSE:BDX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 09, 2026. The Healthcare company reported Q0…
BECTON DICKINSON & CO (NYSE:BDX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 09, 2026.
The Healthcare company reported Q0 revenue of .
BECTON DICKINSON & CO's stock currently trades at $207.39 with a market capitalization of $57.4B.
Current market data
NYSE · BDX
$189.52
Up: +$1.39 · +0.74%
Live quote updated
Keep reading
analyst ·
institutional ·
institutional ·
analyst ·
